期刊
TRENDS IN FOOD SCIENCE & TECHNOLOGY
卷 88, 期 -, 页码 46-56出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tifs.2019.02.003
关键词
beta-Cell dysfunction; Insulin resistance; Sesquiterpenoids; Type 2 diabetes; Key enzyme
资金
- National Natural Science Foundation of China (NSFC) [31701520, 31801459]
- China Postdoctoral Science Foundation [2018M642551]
- Funds for Distinguished Young Scientists at Fujian agriculture and forestry university of China [kxjq17012]
Background: Treatment of type 2 diabetes mellitus (T2DM) through dietary terpenoids is receiving a promising interest and sesquiterpenoids' importance for food and pharmaceutical industries is mainly based on the existed scientific works. Scope and approach: Sesquiterpenoids might contribute to prevent or delay T2DM by inhibiting key enzymes relevant for hyperglycemia, modulating beta-cells function, targeting insulin signaling route, etc. Sesquiterpenoids also have been demonstrated to stimulate glucose uptake by enhancing glucose transport, repressing glucose production, or improving lipid metabolism. Key findings and conclusions: In this review, we summarized the latest developments of sesquiterpenoids in the treatment of type 2 diabetes as well as sesquiterpenoids-rich herbs against key enzymes relevant to hyperglycemia, and discussed their underlying molecular mechanisms of anti-diabetic potential. We also suggested a better evaluation of the pharmacological profile of sesquiterpenoids and their derivate with a clear-cut choice of possible human pathologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据